1. Astrup A. Dietary management of obesity. JPEN J Parenter Enteral Nutr 2008;32:575-7. [DOI via Crossref] [Pubmed] | | 2. Scheffer PG, Tushuizen ME, Vermue HP, Schindhelm RK, Rustemeijer C, Diamant M. Effect of three consecutive meals on the physicochemical properties of HDL and LDL in individuals with the metabolic syndrome and patients with Type 2 diabetes. Eur J Clin Nutr 2011;65:1242-9. [DOI via Crossref] [Pubmed] | | 3. Tushuizen ME, Nieuwland R, Scheffer PG, Sturk A, Heine RJ, Diamant M. Two consecutive high-fat meals affect endothelialdependent vasodilation, oxidative stress and cellular microparticles in healthy men. J Thromb Haemost 2006;4:1003-10. [DOI via Crossref] [Pubmed] | | 4. Patsch W, Esterbauer H, Föger B, Patsch JR. Postprandial lipemia and coronary risk. Curr Atheroscler Rep 2000;2:232-42. [DOI via Crossref] [Pubmed] | | 5. Wallace JP, Johnson B, Padilla J, Mather K. Postprandial lipaemia, oxidative stress and endothelial function: A review. Int J Clin Pract 2010;64:389-403. [DOI via Crossref] [Pubmed] | | 6. Bladbjerg EM, Larsen TM, Due A, Jespersen J, Stender S, Astrup A. Postprandial coagulation activation in overweight individuals after weight loss: Acute and long-term effects of a high-monounsaturated fat diet and a low-fat diet. Thromb Res 2014;133:327-33. [DOI via Crossref] [Pubmed] | | 7. Campbell CG, Brown BD, Dufner D, Thorland WG. Effects of soy or milk protein during a high-fat feeding challenge on oxidative stress, inflammation, and lipids in healthy men. Lipids 2006;41:257-65. [DOI via Crossref] [Pubmed] | | 8. Erridge C, Attina T, Spickett CM, Webb DJ. A high-fat meal induces low-grade endotoxemia: Evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 2007;86:1286-92. | | 9. Herieka M, Erridge C. High-fat meal induced postprandial inflammation. Mol Nutr Food Res 2014;58:136-46. [DOI via Crossref] [Pubmed] | | 10. Raz O, Steinvil A, Berliner S, Rosenzweig T, Justo D, Shapira I. The effect of two iso-caloric meals containing equal amounts of fats with a different fat composition on the inflammatory and metabolic markers in apparently healthy volunteers. J Inflamm (Lond) 2013;10:3. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 11. Strohacker K, Breslin WL, Carpenter KC, Davidson TR, Agha NH, McFarlin BK. Moderate-intensity, premeal cycling blunts postprandial increases in monocyte cell surface CD18 and CD11a and endothelial microparticles following a high-fat meal in young adults. Appl Physiol Nutr Metab 2012;37:530-9. [DOI via Crossref] [Pubmed] | | 12. Alfadda AA, Fatma S, Chishti MA, Al-Naami MY, Elawad R, Mendoza CD, et al. Orosomucoid serum concentrations and fat depot-specific mRNA and protein expression in humans. Mol Cells 2012;33:35-41. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 13. Chen HM, Zheng CX, Gao Q, Ge YC, Liu ZH. Heart-type fatty acid binding protein is associated with proteinuria in obesity. PLoS One 2012;7:e45691. | | 14. Ferrara LA, Capaldo B, Mancusi C, Lee ET, Howard BV, Devereux RB, et al Cardiometabolic risk in overweight subjects with or without relative fat-free mass deficiency: The Strong Heart Study. Nutr Metab Cardiovasc Dis 2014;24:271-6. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 15. Lavoie ME, Rabasa-Lhoret R, Doucet E, Mignault D, Messier L, Bastard JP, et al Association between physical activity energy expenditure and inflammatory markers in sedentary overweight and obese women. Int J Obes (Lond) 2010;34:1387-95. [DOI via Crossref] [Pubmed] | | 16. Lucha-López MO, Lucha-López AC, Vidal-Peracho C, Tricás- Moreno JM, Estébanez-De Miguel E, Salavera-Bordás C, et al Analysis of a sample of Type 2 diabetic patients with obesity or overweight and at cardiovascular risk: A cross sectional study in Spain. BMC Res Notes 2014;7:48. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 17. Rangé H, Poitou C, Boillot A, Ciangura C, Katsahian S, Lacorte JM, et al Orosomucoid, a new biomarker in the association between obesity and periodontitis. PLoS One 2013;8:e57645 . 18. Shearer J, Fueger PT, Bracy DP, Wasserman DH, Rottman JN. Partial gene deletion of heart-type fatty acid-binding protein limits the severity of dietary-induced insulin resistance. Diabetes 2005;54:3133-9. [DOI via Crossref] | | 19. American College of Sports Medicine, Thompson WR, Gordon NF, Pescatello LS. ACSM's Guidelines for Exercise Testing and Prescription. Philadelphia: Lippincott Williams & Wilkins; 2010. p. xxi, 380 . | | 20. Perez-Martinez P, Alcala-Diaz JF, Delgado-Lista J, Garcia-Rios A, Gomez-Delgado F, Marin-Hinojosa C, et al Metabolic phenotypes of obesity influence triglyceride and inflammation homoeostasis. Eur J Clin Invest 2014;44:1053-64. | | 21. McFarlin BK, Venable AS. Measurement of low concentration human serum cytokines using a millipore high-sensitivity milliplex assay. J Vis Exp 2014;94:e52201. | | 22. Lee W, Ku SK, Kim SW, Bae JS. Endocan elicits severe vascular inflammatory responses in vitro and in vivo. J Cell Physiol 2014;229:620-30. [DOI via Crossref] [Pubmed] | | 23. Balta S, Mikhailidis DP, Demirkol S, Ozturk C, Kurtoglu E, Demir M, et al. Endocan – a novel inflammatory indicator in newly diagnosed patients with hypertension: A pilot study. Angiology 2014;65:773-7. [DOI via Crossref] [Pubmed] | | 24. Gijsbers K, Gouwy M, Struyf S, Wuyts A, Proost P, Opdenakker G, et al. GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors. Exp Cell Res 2005;303:331-42. [DOI via Crossref] [Pubmed] | | 25. Lv Y, Hou X, Ti Y, Bu P. Associations of CXCL16/CXCR6 with carotid atherosclerosis in patients with metabolic syndrome. Clin Nutr2013;32:849-54. | | 26. Lo JC, Ljubicic S, Leibiger B, Kern M, Leibiger IB, Moede T, et al. Adipsin is an adipokine that improves ß cell function in diabetes. Cell 2014;158:41-53. [DOI via Crossref] [Pubmed] | | 27. Derosa G, Fogari E, D'Angelo A, Bianchi L, Bonaventura A, Romano D, et al. Adipocytokine levels in obese and non-obese subjects: An observational study. Inflammation 2013;36:914-20. [DOI via Crossref] [Pubmed] | | 28. Theilade S, Lajer M, Jorsal A, Tarnow L, Parving HH, Rossing P. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy. Diabet Med 2012;29:337-44. [DOI via Crossref] [Pubmed] | | 29. Rambod M, Heine GH, Seiler S, Dominic EA, Rogacev KS, Dwivedi R, et al. Association of vascular endothelial factors with cardiovascular outcome and mortality in chronic kidney disease patients: A 4-year cohort study. Atherosclerosis 2014;236:360-5. [DOI via Crossref] [Pubmed] | |
|
|